• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化的肺生理学。

Physiology of the lung in idiopathic pulmonary fibrosis.

机构信息

Service de Pneumologie et Explorations Fonctionnelles Respiratoires, Hôpital Bretonneau, Tours, France.

Université François Rabelais, Tours, France.

出版信息

Eur Respir Rev. 2018 Jan 24;27(147). doi: 10.1183/16000617.0062-2017. Print 2018 Mar 31.

DOI:10.1183/16000617.0062-2017
PMID:29367408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9489199/
Abstract

The clinical expression of idiopathic pulmonary fibrosis (IPF) is directly related to multiple alterations in lung function. These alterations derive from a complex disease process affecting all compartments of the lower respiratory system, from the conducting airways to the lung vasculature. In this article we review the profound alterations in lung mechanics (reduced lung compliance and lung volumes), pulmonary gas exchange (reduced diffusing capacity, increased dead space ventilation, chronic arterial hypoxaemia) and airway physiology (increased cough reflex and increased airway volume), as well as pulmonary haemodynamics related to IPF. The relative contribution of these alterations to exertional limitation and dyspnoea in IPF is discussed.

摘要

特发性肺纤维化 (IPF) 的临床表现与肺功能的多种改变直接相关。这些改变源自影响下呼吸道所有部位的复杂疾病过程,从传导气道到肺血管。在本文中,我们回顾了肺力学(肺顺应性和肺容积降低)、肺气体交换(弥散能力降低、死腔通气增加、慢性动脉低氧血症)和气道生理学(咳嗽反射增加、气道容积增加)以及与 IPF 相关的肺血流动力学的深刻改变。讨论了这些改变对 IPF 中运动受限和呼吸困难的相对贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc7/9489199/3dbc44572d68/ERR-0062-2017.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc7/9489199/48cca994b8b1/ERR-0062-2017.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc7/9489199/3dbc44572d68/ERR-0062-2017.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc7/9489199/48cca994b8b1/ERR-0062-2017.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc7/9489199/3dbc44572d68/ERR-0062-2017.02.jpg

相似文献

1
Physiology of the lung in idiopathic pulmonary fibrosis.特发性肺纤维化的肺生理学。
Eur Respir Rev. 2018 Jan 24;27(147). doi: 10.1183/16000617.0062-2017. Print 2018 Mar 31.
2
Exercise related ventilation dynamics and clinical correlates in patients with fibrotic idiopathic interstitial pneumonias.特发性肺纤维化患者运动相关通气动力学及其临床关联
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Aug 1;33(2):157-65.
3
Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.多次呼吸冲洗:一种用于特发性肺纤维化患者的新型且有前途的肺功能测试。
Respirology. 2018 Aug;23(8):764-770. doi: 10.1111/resp.13294. Epub 2018 Mar 24.
4
Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis.特发性肺纤维化所致肺动脉高压中的低氧性肺血管收缩与弥散能力
J Am Heart Assoc. 2019 Aug 20;8(16):e013310. doi: 10.1161/JAHA.119.013310. Epub 2019 Aug 19.
5
Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.非对称性特发性肺纤维化患者的临床特征
Respir Med. 2016 Oct;119:96-101. doi: 10.1016/j.rmed.2016.08.028. Epub 2016 Aug 31.
6
Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.通过高分辨率计算机断层扫描评估的肺气肿对经外科肺活检诊断的特发性肺纤维化的临床影响。
Respiration. 2016;92(4):220-228. doi: 10.1159/000448118. Epub 2016 Aug 31.
7
Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.间质性肺异常和特发性肺纤维化中气道壁厚度增加。
Ann Am Thorac Soc. 2019 Apr;16(4):447-454. doi: 10.1513/AnnalsATS.201806-424OC.
8
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.特发性肺纤维化急性加重的危险因素:一项系统评价和荟萃分析。
Clin Respir J. 2018 Mar;12(3):1084-1092. doi: 10.1111/crj.12631. Epub 2017 Apr 12.
9
Idiopathic Pulmonary Fibrosis: Review of Current Knowledge.特发性肺纤维化:现有知识综述。
Physiol Res. 2024 Aug 31;73(4):487-497. doi: 10.33549/physiolres.935322.
10
The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.特发性肺纤维化与胸膜肺弹力纤维增生症的异同。
Chron Respir Dis. 2019 Jan-Dec;16:1479973119867945. doi: 10.1177/1479973119867945.

引用本文的文献

1
The Pulmonary Manifestation of Mastocytosis: Experiences of the National Reference Centre of Excellence.肥大细胞增多症的肺部表现:国家卓越参考中心的经验
J Clin Med. 2025 Aug 3;14(15):5455. doi: 10.3390/jcm14155455.
2
Mechanically Tunable Poly(Ethylene Glycol) Diacrylate Hydrogels Reveal Stiffness-Related Impairments in Capillary Sprouting in Experimental Lung Fibrosis.机械可调聚乙二醇二丙烯酸酯水凝胶揭示了实验性肺纤维化中毛细血管生成与刚度相关的损伤。
Microcirculation. 2025 Jul;32(5):e70018. doi: 10.1111/micc.70018.
3
Emphysema: an ignored radiologic sign of diffuse alveolar hemorrhage.

本文引用的文献

1
Using hyperpolarized Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis.使用超极化氙气磁共振成像技术量化特发性肺纤维化中的局部气体交换。
Thorax. 2018 Jan;73(1):21-28. doi: 10.1136/thoraxjnl-2017-210070. Epub 2017 Aug 31.
2
Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.特发性肺纤维化的合并症:识别与管理
Front Med (Lausanne). 2017 Aug 2;4:123. doi: 10.3389/fmed.2017.00123. eCollection 2017.
3
A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis.
肺气肿:弥漫性肺泡出血被忽视的影像学征象。
BMC Pediatr. 2025 Jul 2;25(1):513. doi: 10.1186/s12887-025-05850-y.
4
Effectiveness of inspiratory muscle training in patients with a chronic respiratory disease: an overview of systematic reviews.吸气肌训练对慢性呼吸系统疾病患者的有效性:系统评价概述
Front Sports Act Living. 2025 May 21;7:1549652. doi: 10.3389/fspor.2025.1549652. eCollection 2025.
5
Dynamic perfusion area-detector CT in non-small cell lung cancer with progressive fibrosing interstitial lung disease.动态灌注区域探测器CT在合并进行性纤维化间质性肺病的非小细胞肺癌中的应用
Eur Radiol. 2025 May 22. doi: 10.1007/s00330-025-11653-7.
6
Management strategies and outcomes predictors of interstitial lung disease exacerbation admitted to an intensive care setting: A narrative review.重症监护病房收治的间质性肺疾病急性加重的管理策略及结局预测因素:一项叙述性综述
J Crit Care Med (Targu Mures). 2025 Apr 30;11(2):112-121. doi: 10.2478/jccm-2025-0013. eCollection 2025 Apr.
7
Novel high throughput 3D ECM remodeling assay identifies MEK as key driver of fibrotic fibroblast activity.新型高通量3D细胞外基质重塑检测法确定MEK是纤维化成纤维细胞活性的关键驱动因素。
Mater Today Bio. 2025 Apr 24;32:101800. doi: 10.1016/j.mtbio.2025.101800. eCollection 2025 Jun.
8
Carbon monoxide and nitric oxide diffusion capacity of formerly exposed asbestos workers with high-resolution computed tomography in a cross-sectional study.一项横断面研究中,对曾接触石棉的工人进行高分辨率计算机断层扫描,测定其一氧化碳和一氧化氮弥散能力。
Sci Rep. 2025 May 2;15(1):15380. doi: 10.1038/s41598-025-99824-w.
9
Modified-Release Pulmonary Delivery Systems for Labile Bioactives: Design, Development, and Applications.用于不稳定生物活性物质的缓释肺部给药系统:设计、开发与应用
Pharmaceutics. 2025 Apr 3;17(4):470. doi: 10.3390/pharmaceutics17040470.
10
The use of mechanical ventilation in interstitial lung disease.机械通气在间质性肺疾病中的应用。
Breathe (Sheff). 2025 Apr 17;21(2):240172. doi: 10.1183/20734735.0172-2024. eCollection 2025 Apr.
特罗利单抗治疗特发性肺纤维化患者的 2 期随机对照研究。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):94-103. doi: 10.1164/rccm.201704-0784OC.
4
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis.特发性肺纤维化合并肺气肿时的功能和预后影响。
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.00379-2017. Print 2017 Jul.
5
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.特发性肺纤维化患者肺气肿程度对肺功能的影响。
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1162-1171. doi: 10.1164/rccm.201612-2492OC.
6
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.吡非尼酮可减少特发性肺纤维化患者与呼吸相关的住院次数。
Am J Respir Crit Care Med. 2017 Sep 15;196(6):756-761. doi: 10.1164/rccm.201701-0091OC.
7
Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis.预测吡非尼酮治疗特发性肺纤维化的预期寿命。
J Manag Care Spec Pharm. 2017 Mar;23(3-b Suppl):S17-S24. doi: 10.18553/jmcp.2017.23.3-b.s17.
8
Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia.特发性肺纤维化患者在不伴有静息低氧血症的情况下,急性氧补充可提高耐力和改善呼吸困难。
Respirology. 2017 Jul;22(5):957-964. doi: 10.1111/resp.13002. Epub 2017 Feb 22.
9
Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine.特发性肺纤维化的遗传学:从作用机制到个性化医疗
J Med Genet. 2017 Feb;54(2):93-99. doi: 10.1136/jmedgenet-2016-103973. Epub 2016 Dec 23.
10
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.西妥昔单抗对比安慰剂治疗特发性肺纤维化的疗效:一项随机、双盲、对照、2 期临床试验。
Lancet Respir Med. 2017 Jan;5(1):22-32. doi: 10.1016/S2213-2600(16)30421-0. Epub 2016 Dec 7.